Target intelligence / Profile preview

Mitotic apparatus proteins

Molecular classification
Enzyme, Motor protein, Structural protein, Other
01

Overview

Mitotic apparatus proteins constitute a complex network of structural, motor, and regulatory proteins essential for the assembly and function of the mitotic spindle during cell division (NIH, PubMed). This group includes microtubules (composed of tubulin), motor proteins such as kinesins (e.g., KIF11/Eg5) and dyneins, and regulatory enzymes like Aurora kinases and Polo-like kinases (PLK1) (UniProt, NIH). These proteins ensure the accurate segregation of chromosomes into daughter cells, a process that is tightly regulated by the spindle assembly checkpoint (PubMed). In many cancers, these proteins are overexpressed or dysregulated to support rapid and uncontrolled cell proliferation, making them significant therapeutic targets (Frontiers in Oncology). Drugs targeting this apparatus, such as taxanes (e.g., paclitaxel) and vinca alkaloids (e.g., vincristine), have long been staples of chemotherapy by disrupting microtubule dynamics (PubChem). Newer therapeutic strategies involve small molecule inhibitors of specific mitotic kinases and kinesins, such as alisertib and volasertib, which aim to achieve more selective mitotic arrest and reduce off-target toxicities like peripheral neuropathy (ClinicalTrials.gov). Despite their efficacy, resistance mechanisms such as tubulin mutations and the upregulation of efflux pumps remain significant clinical challenges (PubMed).

Other names
Mitotic spindle proteinsSpindle apparatus proteinsMitotic network proteinsNuclear mitotic apparatus protein 1 (NuMA1)
02

Mechanism of action

Drugs targeting mitotic apparatus proteins primarily act by disrupting the assembly, stability, or dynamics of the mitotic spindle (PubMed). This includes stabilizing microtubules (taxanes) or destabilizing them (vinca alkaloids), inhibiting the activity of essential mitotic kinases such as Aurora A/B and PLK1, or blocking the function of mitotic motor proteins like KIF11/Eg5 (PubChem, NIH). These actions lead to prolonged mitotic arrest at the spindle assembly checkpoint, ultimately triggering programmed cell death (apoptosis) in rapidly dividing cells.

03

Biological functions

Cell cycleCell proliferationChromosome segregationMitosis
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionPeripheral neuropathyNeutropeniaAlopeciaGastrointestinal toxicity
06

Interacting drugs

Paclitaxel

8 more in the full profile.

07

Biomarkers

Mitotic indexKi-67 expressionAurora kinase A expressionPLK1 expressionCENPE expression

Beyond the preview

Go deeper on Mitotic apparatus proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitotic apparatus proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call